By Michael Bartlett on April 14th, 2026 in Ethylene Oxide
One of the most important facts about EtO exposure is that cancer often develops years or decades after the initial exposure. Authoritative sources show that lymphohematopoietic cancers like non-Hodgkin's lymphoma have approximately 4 to 10 years of latency, while solid tumors like breast or lung cancer have 10 to 20+ years of latency.
Major cohort studies, including NIOSH worker studies, specifically model cancer risk using 15-year and 20-year latency windows. This means a person diagnosed with cancer in 2026 may have been exposed in 2006, 1996, or even earlier, depending on exposure duration.
EtO doesn't cause immediate illness. Instead, it works silently at the cellular level over decades. DNA damage begins immediately. EtO is a direct DNA-alkylating agent that binds to DNA and creates mutations and chromosomal damage. Once cells are mutated, they stick around, replicating and accumulating more mutations over time. Decades can pass before those mutations reach critical genes like oncogenes and tumor suppressors, at which point cells become cancerous.
This slow progression explains why exposure in the 1980s or 1990s can lead to diagnosis decades later. The chemical acts as a delayed-action carcinogen, initiating cancer processes that remain dormant for years before becoming clinically detectable.
Industrial sterilization expanded across the U.S. during the 1980s and 1990s. Many facilities operated with higher emissions and fewer controls during this period. DeRoyal began operations in 1983. BD facilities have operated since 1986. Steris began operations in 2016. Early sterilization practices at these older facilities often lacked modern emission controls that exist today.
Some facilities cut their emissions during the 2000s and 2010s, but communities often remained exposed for decades as knowledge of EtO's dangers continued to build. The cancers now being diagnosed in the 2020s fit within 15 to 30-year latency windows and are consistent with years of accumulated exposure from earlier decades.
Epidemiological studies support this timeline, showing that the risk of cancer increases with how long someone is exposed. Large studies of groups of people show a clearer link between exposure and risk when using models that consider a delay of 15 to 20 years. Lymphoid cancers, including NHL, display exposure-response trends once latency is accounted for. The risk is tied to long-term cumulative exposure, not just short bursts of contact.
Exposure risk is tied to where you lived, not where you live now. People who may be affected include:
Even if you moved away from Anoka County, Hidden Valley, or other communities near EtO facilities years ago, cancer may not develop until years after exposure ends. DNA damage persists long after exposure stops. This is why public health agencies emphasize long-term monitoring for exposed populations.
Communities near EtO facilities often share characteristics that increase risk. Long-term residential populations lived in the same areas for decades. Continuous emissions occurred throughout the 1980s, 1990s, and 2000s. Exposure happened during periods of less stringent regulation when facilities operated with fewer emission controls.
Combine these factors with latency periods, and you get a pipeline of future diagnoses tied to past exposure. The National Cancer Institute confirms that EtO exposure is associated with lymphoma, leukemia, and breast cancer, with these cancers often appearing many years after initial exposure.
A 2026 diagnosis can legally trace back to 1980s and 1990s exposure. Past facility emissions remain relevant evidence even if current operations have improved. Courts often consider duration of exposure, proximity to the source, and historical emission levels when evaluating claims.
EtO cases are particularly strong because risk increases with long-term, low-level exposure over many years. Latency science directly counters a common defense argument that exposure is too remote. Scientific evidence shows delayed onset is expected and normal for EtO-related cancers.
This opens claims for former residents who lived near facilities decades ago and individuals diagnosed long after moving away. You don't need to currently live near a facility to have a valid claim if you lived near one during the 1980s, 1990s, or 2000s and have now developed cancer.
If you lived near a DeRoyal, BD, Steris, or other ethylene oxide sterilization facility during the 1980s, 1990s, or 2000s and have been diagnosed with cancer, your diagnosis may be connected to exposure that occurred decades ago. ELG Law has represented toxic exposure victims for over 35 years. Contact us for a free case evaluation to determine whether your cancer diagnosis qualifies for compensation based on past residential exposure to ethylene oxide.